Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Virdante Pharma Lands $30M in A Round to Combat Inflammation Ryan McBride 10/29/09 Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News Rebecca Zacks 10/28/09 Boston
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’ Luke Timmerman 10/23/09 Boston
Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029 Luke Timmerman 10/21/09 Seattle
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten Luke Timmerman 10/08/09 Boston
Bigtime Biotech Thinkers Steven Burrill and Gary Pisano Agree on Bright Future of Industry, Disagree on How to Build Value Ryan McBride 10/08/09 Boston
DC Matters, But Biotech Can’t Neglect City Hall David Miller 10/07/09 Seattle
Ironwood Recruits Genentech, Facebook Star as Company Knocks on Wall Street Doors Luke Timmerman 10/05/09 Boston
Facet Board Recommends Rejecting Biogen Bid Robert Buderi 10/01/09 Boston
Alkermes’ Ambitious Builder, Richard Pops, Grabs Reins to Re-Ignite Growth Phase Luke Timmerman 09/28/09 Boston
A123Systems Pulls Off Big IPO, PrimeraDx Grabs $20M, Conduit Labs Collects $3M, and More Boston-Area Deals News Rebecca Zacks 09/25/09 Boston
Biogen Idec Still Pursuing Facet Acquisition, Helicos Gets $10M Reprieve, Seaside Collects $30M for Autism Drug Development, & More Boston-Area Life Sciences News Rebecca Zacks 09/23/09 Boston
Biogen Tender Offer For Facet Begins Rebecca Zacks 09/21/09 Boston
Tysabri’s Tally of PML Cases Reaches 13 Luke Timmerman 09/17/09 Boston
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News Rebecca Zacks 09/11/09 Boston
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News Luke Timmerman 09/10/09 Seattle
Facet Rejects Biogen Takeover Bid Luke Timmerman 09/08/09 Boston
Sepracor Snatched up for $2.6B, EMC Acquires FastScale and Kazeon, Biogen Makes Bid For Facet, & More Boston-Area Deals News Rebecca Zacks 09/08/09 Boston
Biogen Idec Makes Hostile $350M Takeover Bid for Facet Biotech Luke Timmerman 09/04/09 Boston
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says Luke Timmerman 09/04/09 Boston
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News Rebecca Zacks 09/02/09 Boston
Amylin and Biogen Idec Make Board Changes, Inovio Catches Wave of Investor ‘Swine Flu’ Fervor, Ligand Buys Neurogen, & Other San Diego Life Sciences News Bruce V. Bigelow 08/27/09 San Diego
Biogen Idec Research Boss Quits Board, Giving Icahn Shot at Pushing R&D Agenda Luke Timmerman 08/26/09 Boston
Another Biogen Director to Retire Ryan McBride 08/26/09 Boston
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets Luke Timmerman 08/18/09 San Diego
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News Rebecca Zacks 08/12/09 Boston
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J Ryan McBride 08/06/09 Boston
VC Biotech Funding Rebounds, Biogen Idec Co-Founder Resigns From Board, Pathway Genomics Debuts $250 Personal Genome Test, & More San Diego Life Sciences News Bruce V. Bigelow 07/23/09 San Diego
Biogen Founder Retires From Board, Biopure Goes Broke, Epix Saga Ends, & More Boston-Area Life Sciences News Eric Hal Schwartz 07/22/09 Boston
Replacing Phil Sharp Will Be Up to Biogen’s Board Ryan McBride 07/20/09 Boston
Page 1 of 8 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.